
Tekla Healthcare Investors – NYSE:HQH
Tekla Healthcare Investors stock price today
Tekla Healthcare Investors stock price monthly change
Tekla Healthcare Investors stock price quarterly change
Tekla Healthcare Investors stock price yearly change
Tekla Healthcare Investors key metrics
Market Cap | 788.59M |
Enterprise value | 795.85M |
P/E | 14.01 |
EV/Sales | 9.60 |
EV/EBITDA | 6.48 |
Price/Sales | 9.60 |
Price/Book | 0.78 |
PEG ratio | 0.14 |
EPS | 2.88 |
Revenue | 97.61M |
EBITDA | 143.13M |
Income | 142.61M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 71.74% |
Oper. margin | 87.3% |
Gross margin | 93.48% |
EBIT margin | 87.3% |
EBITDA margin | 146.64% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTekla Healthcare Investors stock price history
Tekla Healthcare Investors stock forecast
Tekla Healthcare Investors financial statements
Mar 2023 | 25.20M | 83.16M | 329.94% |
---|---|---|---|
Jun 2023 | 2.33M | -13.41M | -575.22% |
Sep 2023 | 75.23M | -26.82M | -35.66% |
Mar 2024 | -5.16M | 99.69M | -1930.08% |
Mar 2023 | 990763738 | 11.67M | 1.18% |
---|---|---|---|
Jun 2023 | 932491693 | 1.14M | 0.12% |
Sep 2023 | 932491693 | 1.14M | 0.12% |
Mar 2024 | 1008790426 | 1.10M | 0.11% |
Dec 2022 | 0 | 0 | 0 |
---|---|---|---|
Mar 2023 | 0 | 0 | 0 |
Jun 2023 | 0 | 0 | 0 |
Sep 2023 | 0 | 0 | 0 |
Tekla Healthcare Investors other data
Period | Buy | Sel |
---|---|---|
Sep 2023 | 19000 | 0 |
Dec 2023 | 1170 | 0 |
Jan 2024 | 1000 | 0 |
Apr 2024 | 525 | 0 |
Jul 2024 | 1000 | 0 |
-
What's the price of Tekla Healthcare Investors stock today?
One share of Tekla Healthcare Investors stock can currently be purchased for approximately $16.75.
-
When is Tekla Healthcare Investors's next earnings date?
Unfortunately, Tekla Healthcare Investors's (HQH) next earnings date is currently unknown.
-
Does Tekla Healthcare Investors pay dividends?
Yes, Tekla Healthcare Investors pays dividends and its trailing 12-month yield is 13.85% with 0% payout ratio. The last Tekla Healthcare Investors stock dividend of $0.51 was paid on 31 Dec 2021.
-
How much money does Tekla Healthcare Investors make?
Tekla Healthcare Investors has a market capitalization of 788.59M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 105.35% to 10.29M US dollars.
-
What is Tekla Healthcare Investors's stock symbol?
Tekla Healthcare Investors is traded on the NYSE under the ticker symbol "HQH".
-
What is Tekla Healthcare Investors's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of Tekla Healthcare Investors?
Shares of Tekla Healthcare Investors can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Tekla Healthcare Investors went public?
Tekla Healthcare Investors is publicly traded company for more then 38 years since IPO on 23 Apr 1987.
-
What is Tekla Healthcare Investors's official website?
The official website for Tekla Healthcare Investors is teklacap.com.
-
Where are Tekla Healthcare Investors's headquarters?
Tekla Healthcare Investors is headquartered at 100 Federal Street, Boston, MA.
-
How can i contact Tekla Healthcare Investors?
Tekla Healthcare Investors's mailing address is 100 Federal Street, Boston, MA and company can be reached via phone at +61 77728500.
Tekla Healthcare Investors company profile:

Tekla Healthcare Investors
teklacap.comNYSE
0
Asset Management
Financial Services
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Boston, MA 02110
CIK: 0000805267
ISIN: US87911J1034
CUSIP: 87911J103